Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City

About this update from Eledon Pharmaceuticals, Inc.

[{"type":"image","alt":"Eledon Pharmaceuticals, Inc.","displaySize":"","headline":null,"caption":"Eledon Pharmaceuticals, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":76,"url":"https://media.zenfs.com/en/globenewswire.com/a724d231d4a058286f024bf497bd49c9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/fe3DFQlar3TdaQ4TB5I5xg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwNjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/a724d231d4a058286f024bf497bd49c9","width":300,"height":76}},"lazy":false},{"type":"text","content":"IRVINE, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that it will host an R&D Day in New York City on Wednesday, July 9, 2025 beginning at 8:30 am ET.","length":222,"tagName":"p"},{"type":"text","content":"The event will feature members of Eledon’s executive team and the following leading experts in transplantation:","length":111,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Andrew Adams, M.D., Ph.D., Professor of Surgery and Chief Division of Transplantation, John S. Najarian Surgical Chair in Clinical Transplantation, Department of Surgery, University of Minnesota; Executive Medical Director, Solid Organ Transplant Service Line, M Health Fairview","length":278,"tagName":"p"}]},{"val":[{"type":"text","content":"John D. Cleveland, M.D., Associate Professor of Clinical Surgery, Program Director, Congenital Cardiac Surgery Fellowship, Children’s Hospital Los Angeles, Department of Surgery, Keck School of Medicine","length":202,"tagName":"p"}]},{"val":[{"type":"text","content":"William E. Fitzsimmons, Pharm.D., M.S., Adjunct Professor, University of Illinois Colleges of Medicine and Pharmacy; Executive Committee, Transplant Therapeutics Consortium","length":172,"tagName":"p"}]},{"val":[{"type":"text","content":"Piotr Witkowski, M.D., Ph.D., Professor of Surgery and Director of the Pancreatic and Islet Transplant Program at UChicago Medicine","length":131,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":783,"olType":false},{"type":"text","content":"The R&D Day event will highlight Eledon’s lead investigational candidate, tegoprubart, with a focus on its clinical development in organ and cell transplantation, including the ongoing Phase 2 BESTOW trial. Additional sessions will address...

More updates from Eledon Pharmaceuticals, Inc.